Browse the detailed record of transactions filed by Scalzo Richard William, Autre. Insider active across 2 companies, notably Dyne Therapeutics, Inc.. Cumulatively, 34 reports have been published. Split: 0 buy · 21 sells. Total volume traded: €620k. Activity tracked since 20 September 2021. The latest transaction was filed on 11 March 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Scalzo Richard William
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Scalzo Richard William is Autre, and is listed as SVP, Head of Finance & Admin. at Dyne Therapeutics, Inc. and Chief Financial Officer at CRESCENT BIOPHARMA, INC.. The declarant has 34 filings in total, and, across the recent sampled filings between 2021-09-22 and 2026-06-23, the transactions are mainly disposals for a total of EUR 637770, including amounts of EUR 348681.4799356083 on 2024-03-12, EUR 99142.80544538824 on 2024-08-20, and EUR 73218.97187095207 on 2024-11-18.